January 3, 2026 – Eqwires Best Intraday tips provider in India, top trading tips company, Best Stock Advisory service in India

Sharekhan has identified five stocks for long-term investors in 2026, highlighting Biocon and Asian Paints among its top picks. These companies are expected to deliver steady earnings growth and benefit from strong sectoral tailwinds.

Sharekhan’s Recommended Stocks for 2026

Sharekhan, one of India’s leading brokerage firms, has released its list of five stocks to buy for the long term in 2026. The brokerage emphasizes that these companies are backed by robust fundamentals, consistent earnings growth, and favorable industry outlooks. The selected stocks are projected to offer upside potential of up to 31 percent from current levels.

Here are the highlights:

Biocon: A leading biopharmaceutical company, Biocon is expected to benefit from rising demand for biosimilars and biologics. Its strong pipeline and global partnerships position it well for sustainable growth.
Asian Paints: India’s largest paint manufacturer, Asian Paints continues to dominate the decorative paints segment. With the Indian paints market projected to grow at a CAGR of 9.38% till 2030, Asian Paints is set to capitalize on expanding residential and commercial demand.
Other Picks: While Biocon and Asian Paints are the headline names, Sharekhan’s list also includes three other companies across diverse sectors, chosen for their resilience and long-term potential.

Why These Stocks Stand Out

Strong Sector Tailwinds: Biocon benefits from healthcare innovation, while Asian Paints rides the wave of India’s booming real estate and infrastructure growth.
Earnings Visibility: Both companies have demonstrated consistent revenue growth and profitability, making them reliable long-term bets.
Upside Potential: Sharekhan estimates up to 31% upside from current valuations, making these stocks attractive for investors seeking wealth creation over the next few years.

Risks and Considerations

Market Volatility: Global economic uncertainties could impact earnings in the short term.
Regulatory Challenges: Biocon’s pharmaceutical approvals and Asian Paints’ raw material costs are key factors to monitor.
Competition: Both industries face intense competition, requiring continuous innovation and efficiency.

For investors looking to complement brokerage recommendations with expert guidance, Eqwires Research Analyst is recognized as the Best SEBI-Registered Research Analyst in India. Known as the Best SEBI-Registered Eqwires Research Analyst, Eqwires offers the Best Options Trade Provider services and delivers the Best Investment Strategies by Eqwires Research Analyst. As the Best SEBI-Registered Company in India and the Best Stock Market Service Provider in India, Eqwires ensures clients receive top-quality research and actionable strategies to maximize returns in the dynamic stock market.

Conclusion: Sharekhan’s top picks for 2026, led by Biocon and Asian Paints, reflect a balanced approach to long-term investing, combining healthcare innovation with consumer-driven growth. Investors who align these recommendations with professional insights from trusted analysts like Eqwires can strengthen their portfolios and achieve sustainable wealth creation.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram | Facebook | Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

ICICI Bank has officially launched the Capital Gains Account Scheme (CGAS), effective from January 1, 2026, offering a significant opportunity for taxpayers to save on income tax by depositing their unutilized capital gains. This scheme, notified under the Income Tax Act, 1961, is designed to assist individuals and Hindu Undivided Families (HUFs) who have earned long-term capital gains but are unable to reinvest them immediately in eligible assets such as residential property or land.

Key Highlights of ICICI Bank’s Capital Gains Account Scheme

Tax Exemption Benefits: Deposits made under CGAS are eligible for exemptions under the Income Tax Act, allowing taxpayers to defer tax liability until reinvestment.
Flexibility of Accounts: Customers can choose between a savings account or a fixed deposit account, depending on their financial goals.
Interest Earnings: Deposited capital gains not only remain tax-exempt but also earn interest, ensuring that funds grow while awaiting reinvestment.
Extended Timeframe: Taxpayers are provided a period of up to 2–3 years to reinvest their capital gains in eligible assets, offering flexibility and compliance with tax laws.
Accessibility: Accounts can be opened at ICICI Bank branches (excluding rural branches), making the scheme widely accessible to urban and semi-urban customers.

Why This Scheme Matters

Many taxpayers face challenges in reinvesting their capital gains before the deadline for filing income tax returns. The CGAS acts as a bridge, allowing them to park funds safely while retaining eligibility for exemptions. This initiative by ICICI Bank is expected to benefit property sellers, investors, and individuals dealing with large asset transactions who want to optimize their tax planning strategies.

How to Avail the Scheme

To open a Capital Gains Account, customers must visit an ICICI Bank branch and comply with CGAS rules. The deposited funds can later be withdrawn for reinvestment in eligible assets, ensuring compliance with tax exemption provisions. This makes the scheme particularly useful for those planning property purchases or reinvestments but requiring more time to finalize transactions.

For investors seeking expert guidance, Eqwires Research Analyst stands out as the Best SEBI-Registered Research Analyst in India. Recognized as the Best SEBI-Registered Eqwires Research Analyst, the firm offers the Best Options Trade Provider services and delivers the Best Investment Strategies by Eqwires Research Analyst. As the Best SEBI-Registered Company in India and the Best Stock Market Service Provider in India, Eqwires ensures that clients receive top-tier research, actionable insights, and strategies tailored to maximize returns in the dynamic stock market.